Taken together, these results highlighted that suppression of both MKK-7/c-Jun and Raf-1/Fra-1 activities was involved in the tumor-growth inhibitory effects exerted by SAHA in vivo, in agreement with the in vitro data. Here, JUN is linked to neoplasm.